The first two authors contributed equally to the manuscript Fulminant hepatic failure (FHF) is a devastating clinical syndrome with extremely poor prognosis and high mortality. Therefore, better treatment is urgently needed. Polydatin (PD), a traditional antiinflammatory drug, has been described to protect against liver inj ury induced by certain hepatotoxins. The present study investigated the protective effect of PD against lipopolysaccharide (LPS)ill-galactosamine (D-GaIN)-induced FHF in mice and the underlying mechanism. Mice were pretreated with an increasing dose of PD (10, 30, and 100 mglkg), following LPSID-GaIN challenge. The liver injury was assessed biochemically and histologically. We found that PD exerted a protective effect on LPSID-GaIN-induced FHF as evidenced by reducing sera alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, diminishing liver histopathological injury, and lowering mortality in a dose-dependent manner. In addition, pretreatment mice with PD dose-dependently suppressed tumor necrosis factor-a (TNF-a) production, myeloperoxidase (MPO) activity, intercellular adhesion molecule-l (ICAM-l) and endothelial cell adhesion molecule-l (ECAM-l) expression, caspase-3 activation, and transcription factor nuclear factor-kappa B(NF-KB) activity induced by LPS. These results suggested that PD could effectively protect from LPSID-GaIN-induced FHF and the protective effect afforded by PD probably contributed to reduce TNF-a production via inhibiting NF-kB activation.
necrosis factor-a (TNF-u) and adhesion molecules (5) (6) . Among these pro-inflammatory mediators, TNF-a has been implicated in numerous studies as playing a critical role in the pathogenesis ofFHF. Thereby, it is presumed that treatment strategies for FHF possibly should target cytokines of inflammatory responses especially TNF-a (7) (8) .
Polydatin (PD, Fig. lA) is a glycoside compound isolated from the dried roots ofPolygonum cuspidatum which is a traditional Chinese herbal drug (9) . PD, also named 3, 4', 5-trihydroxystibene-3-p-mono-D-glucoside, is the glycoside of resveratrol (9) (10) . Previous studies demonstrated that PD could inhibit pro-inflammatory cytokines in some inflammatory models (11) (12) . In addition, Huang et al. reported PD could protect primary cultured rat hepatocytes against carbon tetrachloride-induced damage (13) . However, these studies cannot completely reflect whether PD has a beneficial effect on FHF, and its mechanisms of anti-inflammation remain be elusive.
On the basis of PD mentioned above, in this study we assess the protective effect and the mechanism of PD on lipopolysaccharide (LPS) and D-galactosamine (D-GalN)-induced FHF in mice.
MATERIALS AND METHODS

Animals
Balblc mice (6-8 weeks old; weight range: 20-22 g) were obtained from the Laboratory Animal Center of the Chongqing Medical University. They were maintained under controlled conditions (22°C, 55% humidity and 12 h daylnight cycle) and fed standard laboratory chow. They were acclimatized for at least I week before use. All experimental procedures involving animals were approved by the Animal Care and Use Committee of Chongqing Medical University.
Materials
PD (CzoHzps' MW:323, purity2:98%) was purchased from Nanjing Debiochem Co. Ltd. (Nanjing, China). LPS (Escherichia coli, 0111:B4) and D-GaIN were obtained from Sigma (St. Louis, MO, USA). ALT and AST detection kits were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Caspase-3 colorimetric assay kit was purchased from Beyotime Institute of Biotechnology (Nanjing, China). Mouse TNF-a enzyme-linked immunosorbent assay (ELISA) kit was purchased from Bender Med Systems (Vienna, Austria). Intercellular adhesion molecule-I (lCAM-I), endothelial cell adhesion molecule-I (ECAM-I) and b-actin antibodies were products of Abeam (Cambridge, UK). TransAMTM NF-KB p65 transcription factor assay kit was purchased from Active Motif (Carlsbad, USA).
Experimental protocols
The Balblc mice were randomly divided into five groups: control group, LPSID-GaIN group, PD (10 mgl kg)-LPSID-GaIN group, PD (30 mg/kg)-LPSID-GaIN group, PD (100 mg/kg)-LPSID-GaIN group. The model group was injected intraperitoneally with (i.p.) LPS (50 ug/kg) and D-GaIN (700 mg/kg) to induce FHF, PDpretreated groups were pretreated with 200 III of PD (10, 30, 100 mg/kg, respectively) I hour before LPSID-GaIN challenge, the control group received the same volume of sterile saline injection. The survival rate was evaluated within 48 h after LPSID-GaIN administration. Mice were euthanized by decapitation at different time points. Sera and livers were collected for analysis. The dose of PD is based on the results of preliminary experiments in our previous study, and has recently been used in other mice model (14) .
Histopathological analysis
The liver specimens were obtained at 6 h after LPSID-GaIN administration. Then liver tissue was fixed in 10% neutral-buffered formalin and embedded in paraffin. Sections of 5 urn thickness were affixed to slides, deparaffinized, and stained with hematoxylin and eosin to determine morphologic changes.
Evaluation ofhepatotoxicity
Blood was collected from the retro-orbital veins of the eyes 6 h after an LPSID-GaIN injection. The blood samples were centrifuged at 3000 rpm, 10 min. Then the sera were separated and transferred to other tubes and frozen at -20°C. ALT and AST activity was assayed using commercially available kits according to the manufacturer's recommendations.
Hoechst 33342-staining
To analyze the typical morphological signs of apoptosis, paraffin embedded sections were deparaffinized and stained with Hoechst 33342, a fluorescent dye that has been widely used for analysis of nuclear morphology, in an aqueous dilution of I: I0,000 for 5 to 10 min. Hoechst 33342-stained tissue was examined with a fluorescence microscope and photographed. For quantification of apoptosis, 100 nuclei were randomly viewed, and apoptosis was counted.
Caspase-3 protease activity assay
Caspase-3 protease activities In the liver tissue were measured using a caspase-3 colorimetric assay kit according to the manufacturer's instructions. Briefly, after homogenization of whole liver tissue in cell lysis buffer, homogenates were centrifuged for 1 min at 10,000 g, and the supernatant (100 mg protein) was incubated with N-acetyl-Asp-Glu-Val-Asp-p-nitroanilide (Ac-DEVD-pNA) substrate for caspase-3, and reaction buffer for 90 min at 37°C. Absorbance was measured at 405 nrn as caspase protease activity.
Measurement ofTNF-a protein and mRNA levels TNF-u proteins in serum and hepatic tissue were measured by enzyme-linked immunosorbent assay (ELISA) as described by the manufacturer. TNF-a mRNA in hepatic tissue was isolated from hepatic samples using Trizol reagent according to the manufacturer's protocol. Then first-strand complementary DNA (cDNA) ofTNF-a was synthesized. The cDNA samples were then incubated at 90°C for 7 min to stop the reaction. Quantitative PCR was performed with SYBR green PCR Master Mix according to the protocols. For amplification of TNF-a cDNA, the sequences of primers were 5'-TTC TCA TTC CTG CTT GTG GC-3' (sense) and 5'-GTT TGC TAC GAC GTG GGC TA-3' (antisense). The primers used for amplification of GAPDH cDNA: sense, 5'-CCT GCA CCA CCAACT GCT TA-3', and antisense, 5'-TCA TGA GCC CTT CCA CAA TG-3'. The generation of specific PCR products was confirmed by melting-curve analysis. Relative TNF-a mRNAlevels were normalized to GAPDH expression. Data are calculated using the 2-M e t method as described by the manufacturer and are expressed as foldincrease over the indicated controls.
Measurement ofMPO activity
Frozen liver tissues were thawed and homogenized in phosphate buffer containing 0.5% hexadecyltrimethylammonium bromide. The enzyme activity was determined spectrophotometrically using an MPO detection kit according to the manufacturer's instructions. MPO activity was assessed according to the absorbance measured at 450 nrn and normalized by the total protein concentration of the same sample.
Western blotting
The protein of hepatic samples were prepared by the protein extract kit (20 roM Tris, 150 mM NaCl, 1 roM EDTA, 1 mM EGTA, I%TritonX-100, 2.5 mM sodium pyrophosphate, 1 roM Na 3V04 , 1 mM-Glycerolphosphate, 1 ug/ml leupeptin and aprotinin). Protein concentrations were determined by BCA protein assay kit. 40 ug protein extracts were fractionated on 12% polyacrylamidesodium dodecyl sulfate (SDS) gel and then transferred to nitrocellulose membrane. The membrane was blocked with 5% (w/v) fat-free milk in Tris-buffered saline (TBS) containing 0.05% tween-20, followed by incubation with a rabbit primary polyclonal antibody (l :2000) at 4°C overnight. Then the membrane was treated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (l: 10000). Antibody binding was visualized with an enhancer chemiluminescence system and short exposure of the membrane to X-ray films (Kodak, Japan).
NF-KB p65 transcription factor assay
Nuclear protein extracts were obtained from lung tissues using a Nuclear Extract Kit (Active Motif, USA) according to the manufacturer's instructions. The p65 DNA binding activity was assessed by the TransAMTM NF-KB Kit (Active Motif, USA) according to the manufacturer's instructions.
Statistical analysis
Results were analyzed using Student's t-test or by ANOVA where appropriate. All data in this study were expressed as mean±standard error (SD). P values less than or equal to 0.05 were considered significant.
RESULTS
Effects ofPD on LPS/D-GaIN-induced lethality and hepatotoxicity
Because LPS/D-GalN-induced acute liver injury is a severe hepatic failure model, most animals die within 48 h (15) . Thereby, the survival rates were observed every 6 h for 48 h after LPS/D-GalN administration. As presented in Fig. lB. No mice in the model group survived within 48 h after LPS/D-GalN challenged. However, LPS/D-GalN administration, death of mice occurred at 6 h and the lethality reached to 100% at 48 h. Pretreatment with PD (10, 30, 100 mgikg, i.p.) significantly improved the survival rate ofmice. Even at the lowest dose (10 mg/kg), PD improved the survival rate to 20%.
The hepatotoxicity induced by LPS/D-GalN was judged by the pathological injury of liver and the levels of ALT and AST. As shown in Fig. 2 , there is a marked pathological injury in model group, characterized by severe swelling, degeneration and necrosis of hepatocytes, destruction of hepatic architecture, inflammatory infiltration. However, these pathological alterations were dramatically ameliorated in the liver of mice receiving PD pretreatment. Similar to these pathological changes, the data from Fig. 3 showed that sera ALT and AST had a significant elevation at 6 h after injection of LPS/D-GaIN. Compared with the model group, ALT andAST decreased significantly in PD-LPS/D-GaIN groups, especially in PD (100 mg/kg) pretreated group.
Effects ofPDon LPSID-GaiN-inducedhepatocellular apoptosi
Hepatocellular apoptosis was determined by nuclear staining with Hoechst 33342 as described above. Compared to the control group, the model group showed a remarkable of hepatocellular apoptosis, as assayed by reduced size of nuclei, and pyknotic nuclei that condensed and marginated along the periphery of the nuclear membrane. It was found that LPS/D-GaIN-induced apoptotic hepatocytes were notably decreased by 100 mglkg PD pretreatment (Fig. 4A) . Likewise, in the model group, the caspase-3 activity was markedly higher than that of the control group, which was alleviated by the pretreatment of PD in a dose-dependent manner (Fig. 4B ).
Effects of PD on LPSID-GaIN-induced hepatic inflammation
To examine whether PD affects LPS/D-GaINinduced inflammatory response, the expressions of ICAM-I, ECAM-I and MPO activity in liver were examined. The injection of LPS/D-GaIN resulted in higher ICAM-I, ECAM-I expression and MPO activity than these the control group. In contrast, the (Fig. 5, A and B) .
Effects of PD on LPS/D-GaIN-induced TNF-a production
To determine the effects of PD on inflammatory cytokines involved in the hepatotoxicity of LPS/ D-GaIN, TNF-a levels in serum and liver were determined by ELISA and realtime RT-PCR. As shown in Fig. 6 , TNF-a was markedly elevated after LPS/D-GaIN injection compared to the control group. The parallel reductions of both hepatic and serum TNF-n were observed by PD pretreatment. In addition, a similar result was observed on hepatic TNF-a mRNA expression.
Effects of PD on LPS/D-GaIN-induced activity of NF-KB
To gain further insight into the effect of PD on LPS/D-GaIN-induced signaling activation, p65, as an index ofNF-KB activation, was assayed by using a NF-KB p65 transcription factor assay method. As shown in Fig. 7 , NF-KB activity markedly increased in the model group in comparison to the control group. Interestingly, the pretreatment with PD . significantly reduced NF-KB activity to a certain degree, the lowest activity of NF-KB was observed in the D (100 mg/kg) pretreated group.
DISCUSSION
LPS is a major integral structural component of the outer membrane of gram-negative bacteria (16) . It stimulates the production ofa variety of proinflammatory cytokines, finally resulting in systemic inflammatory response and organ function failure (17) . D-GaIN, an amino sugar selectively metabolized by the hepatocyte, is authenticated to enhance the sensitivity of hepatocytes to inflammatory injury (18) . With administration of D-GaIN together with a subtoxic dose of LPS, mice highly sensitive to D-GaIN would develop acute hepatoxicity and lethal shock (19) . Consequently, the model induced by LPS/D-GaIN has been widely used to study the effects and the potential underlying mechanisms of agents on FHF (15, 20) . In the present study, it was demonstrated that PD had a protective effect on LPS/D-GaIN-induced liver injury, as evidenced by reversing the elevation of AST and ALT, preventing severe liver histopathologic damage, and decreasing high mortality TNF-a, a pro-inflammatory mediator, is considered to contribute pivotally to the onset of acute liver injury (21) . Previous study confirmed that administration ofanti-TNF-a antibodies rescued the W/BFl mice from LPS-induced death (22) . Moreover, inflammatory response was decreased in research with TNF-receptor p55 knockout mice or TNF-a knockout in response to LPS (23) (24) . In agreement with these findings, convincing evidence showed that in C3H/HeJ mice TNF-a was hyporesponsive to LPS due to point mutation of the gene encoding Toll-like receptor-4 which is a receptor for LPS (25) . On the other hand, TNF-a is able to prime an apoptotic death program which can be rapidly triggered by different stimuli (26) . Previous studies have reported that apoptosis caused by LPS/D-GaIN was mainly dependent on caspase-3 (27) . Caspase-3 acted as the central effect protease catalyzing the specific cleavage of many key cellular proteins during apoptosis (20, 22, 26) . Furthermore, several pieces of evidence suggested that using caspase inhibitors reduces TNF-a-mediated liver injury (27) .
In the present study, the elevations of TNF-a in serum and liver tissue as well as TNF-a mRNA were observed in the model group, which was attenuated by PD. Meanwhile, the PD-pretreated groups showed significantly less apoptosis and inflammation as compared with the model group, which indicated PD might relieve apoptosis and inflammation through inhibiting TNF-a production. In fact, it has recently been reported that PD inhibited hepatic TNF-a mRNA production in a high-fat diet and carbon tetrachloride-induced liver diseases ( 14, 28) . These findings indicated that this effect of PD might take place through inhibiting upstream signal pathway of TNF-a expression in different liver injury model s.
Neutrophil recruitment as well as the interaction between neutrophils and endothelial cells has been shown to play an important role in the inflammatory response (29) (30) . Neutrophil recruitment is regulated by various adhesion molecules including ECAMland ICAM-l. ICAM-I constitutively expressed at low levels on the endothelial cell (EC) surface and was upregulated by inflammatory cytokines. Thus , ICAM-I has been identified as an essential signaling molecule for leukocyte rolling and diapedesis (31) . Similarly, most evidence suggested leukocyte adhesion and transmigration across the endothelium require ECAM-I expression (32) (33) . Using the Chemotactic chamber assay method, Huang et al. reported that PD alleviated LPS-induced neutrophil chemotaxis (12) .Amore recent study showed also that PD decreased the expression of adhesion molecules, ICAM-I and VCAM-I , in cultured endothelial cells induced by TNF-a (11) . Therefore, we sought to test the hypothesis whether PD could suppress hepat ic GaIN group. The results above all indicated that PD might attenuate the inflammatory response by downregulating adhesion molecules and MPO to protect against LPSID-GalN-induced acute liver injury. NF-KE, typically existing as a dimer of the p65 and p50 subunits, is considered as a key mediator in apoptosis and inflammation (35) (36) . It was demonstrated that TNF-a was reduced in NF-KEdeficient mice (37) . In its dormant state, NF-KB binding to its inhibitor protein IKE resided in the cytosol. Upon activation by cytokines, IKE was phosphorylated by Ixls-kinases (IKKs) and then dissociated from NF-KE (35) . NF-KE without IKE entered the nucleus and subsequently bound to the promoters of some pro-inflammatory cytokine genes. Finally, the expressions of pro-inflammatory cytokines were up-regulated (38) . During this process, especially in the inflammatory response induced by LPS, translocation of the p65 subunit was an important step. Thus, the level ofp65 subunit ofNF-KE in the nucleus was used as an index ofNF-KE activation caused by LPS stimulation (39) . As shown in our data, LPSID-GalN stimulation resulted in the elevation of the NF-KE p65, while it was reversed by PD in a dose-dependent manner. These observations revealed that PD probably suppressed the transcription of TNF-a by inhibiting NF-KE activation. In line with this, Huang et al. and Deng et al. have reported that PD can inhibit activation ofthe NF-KE pathway to reduce inflammatory response (11) (12) .
Our results suggested PD had a protective effect against LPSID-GalN-induced FHF. It was reasonable to hypothesize that suppression of mediated NF-KE activation, reduced TNF-a production, attenuated necrosis and apoptosis, alleviated hepatic injury, and finally reduced mortality in mice. Thereby, PD may contribute to treat FHF in clinical situations.
